Brexit: Bids In For The EMA As Portugal Drops Lisbon For Porto, Bratislava Emerges As Possible Front-Runner
Executive Summary
All bids to host the European Medicines Agency were to have been in by close of business on July 31. Portugal has unexpectedly switched its candidacy from Lisbon to Porto, Bratislava could emerge as a surprise favorite. Meanwhile the CEO of AstraZeneca has said investment decisions are being put on hold pending more clarity over Brexit.
You may also be interested in...
19 Countries Have Submitted Bids To Host The EMA Post-Brexit
Formal offers to host the European Medicines Agency were received from 19 countries by the deadline of July 31. The European Commission will now begin assessing the bids on the basis of six criteria, with a final decision expected in November.
Pharma Execs Urge Post-Brexit Regulatory Deal, As EMA Focuses On Redistribution Of MHRA Work
Spurred by an apparent shift towards a more pro-business stance among government ministers, a number of top pharmaceutical executives and heads of UK industry bodies have publicly called for some form of regulatory alignment deal between the UK and the EU after Brexit.
EU Postpones Decision On EMA’s New Home To November
The decision on where the European Medicines Agency should be located after the UK leaves the EU has been postponed to November. The European Council has published details of the bidding process countries must follow if they want to host the EMA.